EA201992005A1 - Aryl, heteroaryl and heterocyclic pharmaceutical compounds for the treatment of medical disorders - Google Patents

Aryl, heteroaryl and heterocyclic pharmaceutical compounds for the treatment of medical disorders

Info

Publication number
EA201992005A1
EA201992005A1 EA201992005A EA201992005A EA201992005A1 EA 201992005 A1 EA201992005 A1 EA 201992005A1 EA 201992005 A EA201992005 A EA 201992005A EA 201992005 A EA201992005 A EA 201992005A EA 201992005 A1 EA201992005 A1 EA 201992005A1
Authority
EA
Eurasian Patent Office
Prior art keywords
formula
heteroaryl
aryl
treatment
pharmaceutical compounds
Prior art date
Application number
EA201992005A
Other languages
Russian (ru)
Inventor
Джейсон Аллан Уайлс
Авинаш С. Фадке
Милинд Дешпанде
Атул Агарвал
Давэй Чэнь
Венкат Рао Гадхачанда
Акихиро Хашимото
Годвин Пэйс
Цюпин Ван
Сянчжу Ван
Джоэль Чарльз Бэрриш
Уилльям Гринли
Кайл Дж. Истман
Original Assignee
Ачиллион Фармасьютикалс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ачиллион Фармасьютикалс, Инк. filed Critical Ачиллион Фармасьютикалс, Инк.
Priority claimed from PCT/US2018/020528 external-priority patent/WO2018160889A1/en
Publication of EA201992005A1 publication Critical patent/EA201992005A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/027—Organoboranes and organoborohydrides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Предложены ингибиторы фактора D, фармацевтические композиции и их применение, а также способы их получения. Предложенные соединения включают соединения формулы (I), формулы (II), формулы (III), формулы (IV) и формулы (V) или их фармацевтически приемлемую соль, пролекарство, изотопный аналог, N-оксид или выделенный изомер, необязательно в фармацевтически приемлемой композиции. Описанные здесь ингибиторы нацелены на фактор D и ингибируют или регулируют каскад комплемента.Factor D inhibitors, pharmaceutical compositions and their use, as well as methods for their preparation are proposed. Compounds of the invention include compounds of formula (I), formula (II), formula (III), formula (IV) and formula (V), or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein are targeted to factor D and inhibit or regulate the complement cascade.

EA201992005A 2017-03-02 2018-03-01 Aryl, heteroaryl and heterocyclic pharmaceutical compounds for the treatment of medical disorders EA201992005A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762466301P 2017-03-02 2017-03-02
PCT/US2018/020528 WO2018160889A1 (en) 2017-03-01 2018-03-01 Aryl, heteroary, and heterocyclic pharmaceutical compounds for treatment of medical disorders

Publications (1)

Publication Number Publication Date
EA201992005A1 true EA201992005A1 (en) 2020-03-13

Family

ID=69942830

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201992005A EA201992005A1 (en) 2017-03-02 2018-03-01 Aryl, heteroaryl and heterocyclic pharmaceutical compounds for the treatment of medical disorders

Country Status (1)

Country Link
EA (1) EA201992005A1 (en)

Similar Documents

Publication Publication Date Title
MX2023002688A (en) Aryl, heteroary, and heterocyclic pharmaceutical compounds for treatment of medical disorders.
EA201891191A1 (en) 2-SUBSTITUTED HINAZOLIN COMPOUNDS CONTAINING A SUBSTITUTED HETEROCYCLIC GROUP AND METHODS OF THEIR APPLICATION
EA201891091A1 (en) JAK KINASE INHIBITOR COMPOUNDS FOR THE TREATMENT OF RESPIRATORY DISEASE
EA201691803A1 (en) HUMAN PLASMA KALLIKREIN INHIBITORS
EA201992126A1 (en) JAK INHIBITORS CONTAINING 4-MEMBER HETEROCYCLIC AMIDE
EA201792214A1 (en) COMPOUNDS OF SUBSTITUTE QUINAZOLINE
EA201790078A1 (en) MNK INHIBITORS AND RELATED METHODS
EA201690752A1 (en) INHIBITORS G12C KRAS
EA202090530A1 (en) 1-BENZYL-2-IMINO-4-PHENYL-5-OXOIMIDAZOLIDINE DERIVATIVES AS HIV PROTEASE INHIBITORS
EA201991884A3 (en) G12C KRAS INHIBITORS
EA201891063A1 (en) DERIVATIVES OF DIHYDROIMIDAZOPIRAZINONE APPLICABLE IN THE TREATMENT OF CANCER
EA202190681A1 (en) DIMETHYLAMINOAZETIDINE AMIDES AS JAK INHIBITORS
EA201790088A1 (en) SYK INHIBITORS
TR201816176T4 (en) Novel compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions containing the same.
EA201692268A1 (en) PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS
EA202190686A1 (en) 5-7-MEMBER HETEROCYCLIC AMIDES AS JAK INHIBITORS
PH12019500036A1 (en) Heterocyclic compound used as fgfr inhibitor
EA201792425A1 (en) TRICYCLIC COMPOUNDS AND THEIR APPLICATION AS PHOSPHODYSTERASE INHIBITORS
EA201990678A1 (en) Heteroarylcarboxamide Compounds as Ripk2 Inhibitors
EA202191548A1 (en) HUMAN PLASMA CALLICREIN INHIBITORS
EA201692300A1 (en) DERIVATIVES OF CARBOXAMIDE
EA202190588A1 (en) HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS
EA202191478A1 (en) HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS
EA201890534A1 (en) NEW ANNELED PHENOXYCETAMIDES
EA201991355A1 (en) IMIDAZO [1,5-A] PYRASINE DERIVATIVES AS PI3K DELTA INHIBITORS